Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
22.48%
Price
20:05
€348.50
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 22.48%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.237% | 4.237% |
| iShares Core DAX® | 3,15 % | 1,50 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % |
| iShares S&P 500 | 4,58 % | 1,92 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat